1. Home
  2. RAPT vs BRLS Comparison

RAPT vs BRLS Comparison

Compare RAPT & BRLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • BRLS
  • Stock Information
  • Founded
  • RAPT 2015
  • BRLS 2019
  • Country
  • RAPT United States
  • BRLS Canada
  • Employees
  • RAPT N/A
  • BRLS N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • BRLS
  • Sector
  • RAPT Health Care
  • BRLS
  • Exchange
  • RAPT Nasdaq
  • BRLS NYSE
  • Market Cap
  • RAPT 117.5M
  • BRLS 130.4M
  • IPO Year
  • RAPT 2019
  • BRLS N/A
  • Fundamental
  • Price
  • RAPT $0.79
  • BRLS N/A
  • Analyst Decision
  • RAPT Hold
  • BRLS
  • Analyst Count
  • RAPT 7
  • BRLS 0
  • Target Price
  • RAPT $5.00
  • BRLS N/A
  • AVG Volume (30 Days)
  • RAPT 1.1M
  • BRLS 3.7K
  • Earning Date
  • RAPT 05-08-2025
  • BRLS 04-15-2025
  • Dividend Yield
  • RAPT N/A
  • BRLS N/A
  • EPS Growth
  • RAPT N/A
  • BRLS N/A
  • EPS
  • RAPT N/A
  • BRLS N/A
  • Revenue
  • RAPT N/A
  • BRLS $27,668,894.00
  • Revenue This Year
  • RAPT N/A
  • BRLS N/A
  • Revenue Next Year
  • RAPT N/A
  • BRLS N/A
  • P/E Ratio
  • RAPT N/A
  • BRLS N/A
  • Revenue Growth
  • RAPT N/A
  • BRLS N/A
  • 52 Week Low
  • RAPT $0.79
  • BRLS $3.71
  • 52 Week High
  • RAPT $8.58
  • BRLS $10.75
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 31.31
  • BRLS 50.01
  • Support Level
  • RAPT $0.81
  • BRLS $5.76
  • Resistance Level
  • RAPT $0.98
  • BRLS $6.13
  • Average True Range (ATR)
  • RAPT 0.10
  • BRLS 0.20
  • MACD
  • RAPT -0.03
  • BRLS 0.00
  • Stochastic Oscillator
  • RAPT 7.72
  • BRLS 25.62

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About BRLS BOREALIS FOODS INC

Borealis Foods Inc is a food technology company that has developed high-quality, affordable, sustainable, and nutritious ready-to-eat meals. It is a mission-driven company committed to utilizing its products to help solve national and global food security and nutrition challenges. Its commitment to nutrition, affordability, and sustainability reflects its goal of positively impacting both human life and the planet. Through the development and launch of its ready-made ramen, featuring 20 grams of complete plant-based protein per serving, Borealis is developing advanced solutions to address global food challenges.

Share on Social Networks: